| APOL1 |
apolipoprotein L1 |
0 |
| APOL2 |
apolipoprotein L2 |
0 |
| APOL3 |
apolipoprotein L3 |
0 |
| APOL4 |
apolipoprotein L4 |
0 |
| APOL5 |
apolipoprotein L5 |
0 |
| APOL6 |
apolipoprotein L6 |
0 |
| APOM |
apolipoprotein M |
0 |
| APONP |
apolipoprotein N, pseudogene |
0 |
| APOO |
apolipoprotein O |
0 |
| APOOL |
apolipoprotein O like |
0 |
| APOOP1 |
apolipoprotein O pseudogene 1 |
0 |
| APOOP2 |
apolipoprotein O pseudogene 2 |
0 |
| APOOP3 |
apolipoprotein O pseudogene 3 |
0 |
| APOOP4 |
apolipoprotein O pseudogene 4 |
0 |
| APOOP5 |
apolipoprotein O pseudogene 5 |
0 |
| APPAT |
atherosclerotic plaque pathogenesis associated transcript |
0 |
| APPBP2 |
amyloid beta precursor protein binding protein 2 |
0 |
| APPBP2-DT |
APPBP2 divergent transcript |
0 |
| APP-DT |
APP divergent transcript |
0 |
| APPL1 |
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 |
0 |
| APPL2 |
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2 |
0 |
| APRG1 |
APRG1 tumor suppressor candidate |
0 |
| APRT |
adenine phosphoribosyltransferase |
0 |
| APTR |
Alu-mediated CDKN1A/p21 transcriptional regulator |
0 |
| APTX |
aprataxin |
0 |